The antimicrobial peptide dermaseptin S4 inhibits HIV-1 infectivity in vitro (Q40444626)

20 September 2017

The antimicrobial peptide dermaseptin S4 inhibits HIV-1 infectivity in vitro (English)

1 reference

20 September 2017

0 references

1 reference

antimicrobial peptide

1 reference

9

Frédéric Tangy

1 reference

20 September 2017

Clarisse Lorin

1

1 reference

20 September 2017

Héla Saidi

2

1 reference

20 September 2017

Afifa Belaid

3

1 reference

20 September 2017

Amira Zairi

4

1 reference

20 September 2017

Françoise Baleux

5

1 reference

20 September 2017

Hakim Hocini

6

1 reference

20 September 2017

Laurent Bélec

7

1 reference

20 September 2017

Khaled Hani

8

1 reference

20 September 2017

language of work or name

English

0 references

publication date

1 April 2005

1 reference

20 September 2017

12

1 reference

based on heuristic

inferred from page(s)

published in

Virology

1 reference

20 September 2017

334

1 reference

20 September 2017

2

1 reference

20 September 2017

264-275

1 reference

In vitro antiviral activity of dermaseptins against herpes simplex virus type 1.

20 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.02.002

Solution structure of a cyanovirin-N:Man alpha 1-2Man alpha complex: structural basis for high-affinity carbohydrate-mediated binding to gp120

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.02.002

Transcytosis of infectious human immunodeficiency virus across a tight human epithelial cell line barrier

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.02.002

Entry of viruses through the epithelial barrier: pathogenic trickery

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.02.002

Intracellular Neutralization of HIV Transcytosis across Tight Epithelial Barriers by Anti-HIV Envelope Protein dIgA or IgM

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.02.002

The topical microbicide PRO 2000 protects against genital herpes infection in a mouse model

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.02.002

Inhibition of HIV infectivity by a natural human isolate of Lactobacillus jensenii engineered to express functional two-domain CD4

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.02.002

HIV-1 Reverse Transcription A Termination Step at the Center of the Genome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.02.002

The plasma membrane of Leishmania donovani promastigotes is the main target for CA(1-8)M(1-18), a synthetic cecropin A-melittin hybrid peptide

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.02.002

Mechanisms of viral membrane fusion and its inhibition

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.02.002

Direct interaction of dermaseptin S4 aminoheptanoyl derivative with intraerythrocytic malaria parasite leading to increased specific antiparasitic activity in culture

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.02.002

Structure-activity relationship study of antimicrobial dermaseptin S4 showing the consequences of peptide oligomerization on selective cytotoxicity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.02.002

Analysis of Membrane-Binding Properties of Dermaseptin Analogues: Relationships between Binding and Cytotoxicity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.02.002

The role of sexually transmitted diseases in HIV transmission

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.02.002

DC-SIGN, a dendritic cell-specific HIV-1-binding protein that enhances trans-infection of T cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.02.002

Inhibition of HIV-1 infection by a CCR5-binding cyclophilin from Toxoplasma gondii

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.02.002

Parameters of human immunodeficiency virus infection of human cervical tissue and inhibition by vaginal virucides

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.02.002

Cellulose acetate phthalate (CAP): an 'inactive' pharmaceutical excipient with antiviral activity in the mouse model of genital herpesvirus infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.02.002

Mandelic acid condensation polymer: novel candidate microbicide for prevention of human immunodeficiency virus and herpes simplex virus entry

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.02.002

Active and selective transcytosis of cell-free human immunodeficiency virus through a tight polarized monolayer of human endometrial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.02.002

Blockade of attachment and fusion receptors inhibits HIV-1 infection of human cervical tissue

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.02.002

Potent suppression of HIV-1 replication in humans by T-20, a peptide inhibitor of gp41-mediated virus entry

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.02.002

Determinants of HIV-1 shedding in the genital tract of women.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.02.002

Structural requirements for potent versus selective cytotoxicity for antimicrobial dermaseptin S4 derivatives.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.02.002

Prevention of vaginal SHIV transmission in rhesus macaques through inhibition of CCR5.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.02.002

A single injection of recombinant measles virus vaccines expressing human immunodeficiency virus (HIV) type 1 clade B envelope glycoproteins induces neutralizing antibodies and cellular immune responses to HIV.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.02.002

The entry of entry inhibitors: a fusion of science and medicine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.02.002

Isolation, amino acid sequence, and synthesis of dermaseptin, a novel antimicrobial peptide of amphibian skin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.02.002

Selective interactions of polyanions with basic surfaces on human immunodeficiency virus type 1 gp120

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.02.002

Antibacterial properties of dermaseptin S4 derivatives with in vivo activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.02.002

HIV entry inhibitors in clinical development

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.02.002

HIV-1 entry inhibitors: new targets, novel therapies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.02.002

gp120: Biologic aspects of structural features

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.02.002

In vitro inactivation of HIV-1 by contraceptive sponge containing nonoxynol-9

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.02.002

Transmission, acute HIV-1 infection and the quest for strategies to prevent infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.02.002

A humanized, nondepleting anti-CD4 antibody that blocks virus entry inhibits virus replication in rhesus monkeys chronically infected with simian immunodeficiency virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.02.002

Crystal structure of a neutralizing human IGG against HIV-1: a template for vaccine design

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.02.002

Mechanism of the binding, insertion and destabilization of phospholipid bilayer membranes by alpha-helical antimicrobial and cell non-selective membrane-lytic peptides

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.02.002

Inhibiting sexual transmission of HIV-1 infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.02.002

Cellular targets of infection and route of viral dissemination after an intravaginal inoculation of simian immunodeficiency virus into rhesus macaques

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.02.002

Microbicides: a new approach to preventing HIV and other sexually transmitted infections

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.02.002

Spectrum of antimicrobial activity and assembly of dermaseptin-b and its precursor form in phospholipid membranes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.02.002

Effectiveness of COL-1492, a nonoxynol-9 vaginal gel, on HIV-1 transmission in female sex workers: a randomised controlled trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.02.002

Retrocyclin, an Antiretroviral θ-Defensin, Is a Lectin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.02.002

The antigenic structure of the HIV gp120 envelope glycoprotein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.02.002

Activity of dermaseptin K4-S4 against foodborne pathogens.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.02.002

10.1016/J.VIROL.2005.02.002

7 January 2021

Identifiers

DOI

1 reference

20 September 2017

1 reference